EFSD/Lilly Young Investigator Research Award Programme


Elena Carcarino: French National Institute of Health and Medical Research - Paris, France
Epigenomic regulation of IL1B enhancers in type 2 diabetes

Lærke Smidt Gasbjerg: University of Copenhagen - Denmark
The role of the intestinal hormones GIP and GLP-2 in human gastrointestinal blood supply and metabolism

Anne Gemmink: Maastricht University - Netherlands
Opening the door towards improved insulin sensitivity; promoting myocellular lipid droplet dynamics

Zhiqiang Huang: Karolinska Institute - Stockhom, Sweden
Epigenetic remodelling of monocyte/macrophage CCL2 in obesity-induced metabolic disorders

Abraham Meijnikman: Amsterdam UMC - Netherlands
Targeting cellular senescence in individuals with type 2 diabetes with Non-Alcoholic Fatty Liver disease

Chiara Saponaro: Inserm U1190 - Lille, France
Expression and regulation of SGLT2 in human intestine: its role in intestinal glucose absorption and hormone response

Marcela Parra Vargas: SJD Barcelona Children’s Hospital - Spain
Understanding hypertrophic adiposity-associated diabetes in children through single nucleus RNA-sequencing

Ronan Thibaut: Cordeliers Research Center - Paris, France
Metabolic adaptation of liver macrophages in non-alcoholic fatty liver disease in insulin resistance


Brendan Gabriel: University of Edinburgh - United Kingdom
Using chrono-medicine to optimise concomitant metformin and exercise prescription

Rasmus Kjøbsted: University of Copenhagen - Denmark
Role of skeletal muscle AMPK for the regulation of metformin action


Giorgio Caratti: University of Ulm - Germany
The glucocorticoid receptor in macrophages protects against fatty liver degeneration

Antonios Chatzigeorgiou: Medical School, National and Kapodistrian University of Athens - Greece
Immune regulation of cardiometabolic disease in obesity-induced diabetes

Francesca Cinti: Università Cattolica del Sacro Cuore - Rome, Italy
Investigating the role of islet innervation in human beta cell dedifferentiation and type 2 diabetes

Lucile Dollet: Karolinska Institutet - Solna, Sweden
Time-targeted exercise to fight type 2 diabetes: investigating the role of adipose tissue

Teresa Vanessa Fiorentino: University Magna Græcia of Catanzaro - Italy
Intestinal FXR/FGF-19/tight-junctions axis in the pathogenesis of type 2 diabetes and prediabetes

Alba Gonzalez-Franquesa: University of Copenhagen - Denmark
Deciphering the dynamics of mitochondrial supercomplexes in diabetic and exercised skeletal muscle

George Mcilroy: University of Aberdeen - United Kingdom
Identifying novel therapies to prevent diabetes in congenital lipodystrophy

Ivana Nikolic: Centro Nacional de Investigaciones Cardiovasculares Carlos III - CNIC - Madrid, Spain
T cells and stress - novel regulators of obesity development

Berit Svendsen: University of Copenhagen - Denmark
Intra-islet communication and influence on glucose regulation


Stefano Berre: Cochin Institute - Paris, France
Pathogenic vs benign autoimmunity: why are autoimmune CD8+ T cells primed only in patients with type 1 diabetes?

Mariëtte Boon: Leiden University Medical Centre - Netherlands
Towards a new gold standard to quantify brown fat activity in humans

Erez Dror: Max Planck Institute for Immunobiology and Epigenetics - Freiburg, Germany
Unravelling epigenetically distinct beta cell subsets

Claire Lyons: Lund University - Sweden
Investigating the role of melatonin signalling on metabolic dysfunction in pancreatic islets

Lisa Nicholas: University of Cambridge - UK
Exploring sex-specific programming of islet mRNAs by maternal diet-induced obesity

Christoph Nowak: Karolinska Institute - Stockholm, Sweden
Metabolomics of adverse outcomes in type 2 diabetes: risk prediction, causality and sex differences

Adrien Pasquier: Telethon Institute of Genetics and Medicine - Pozzuo, Italy
Impact of lysosomal biogenesis in pancreatic beta cells

Roksana Pirzgalska: Champalimaud Foundation - Lisbon, Portugal
Neuroimmune approach to diabetes-associated infections

Sumeet Singh: TU Dresden - Germany
The role of tetraspanin-7, an islet autoantigen, in regulating beta cell functional heterogenity